Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy

Published:2019-01-03 Issue:6 Volume:78 Page:849-850
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Chen Yi-Ming,Huang Wen-Nan,Liao Tsai-Ling,Chen Jun-Pen,Yang Sheng-Shun,Chen Hsin-Hua,Hsieh Tsu-Yi,Hung Wei-Ting,Chen Yi-Hsing,Chen Der-Yuan

Funder

Taichung Veterans General Hospital

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis

2. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

3. Rituximab may cause increased hepatitis C virus viremia in rheumatoid arthritis patients through declining exosomal MicroRNA-155;Liao;Arthritis Rheumatol,2018

4. Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection

5. Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy;Frontiers in Immunology;2024-06-24

2. Exosomal microRNAs as biomarkers for viral replication in tofacitinib-treated rheumatoid arthritis patients with hepatitis C;Scientific Reports;2024-01-10

3. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks;Inflammatory Bowel Diseases;2022-08-30

4. Hepatitis Viruses;Infectious Complications in Biologic and Targeted Therapies;2022

5. Review article: safety of new biologic agents for inflammatory bowel disease in the liver;European Journal of Gastroenterology & Hepatology;2021-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3